Cigna (CI) Attracts Analyst Attention with Positive Outlooks

Goldman Sachs Initiates Coverage:: On October 14, 2025, Goldman Sachs initiated coverage of Cigna (CI) with a Buy rating and a price target of $370. They anticipate a margin recovery phase starting in 2026, particularly in the Medicare Advantage sector.

*Why this matters:* This endorsement from a major financial institution can boost investor confidence and potentially drive up the stock price.

Wells Fargo Raises Price Target:: On October 7, Wells Fargo increased its price target for Cigna to $354 from $340, maintaining an Equal Weight rating. This adjustment reflects an updated outlook for the sector ahead of Q3 2025 earnings, considering the probable extension of enhanced subsidies.

*Why this matters:* An increased price target indicates that Wells Fargo sees more value in Cigna's stock than previously estimated, suggesting positive future performance.

Dividend Growth:: Cigna has raised its dividend for five consecutive years and currently offers a quarterly dividend of $1.51 per share with a dividend yield of 2.00% (as of October 14, 2025).

*Why this matters:* Consistent dividend increases can attract income-focused investors, providing stability and potential for long-term growth.

Q: What is the current dividend yield of Cigna?

Q: What is the analyst consensus for Cigna?

Cigna is receiving positive attention from analysts at Goldman Sachs, Wells Fargo, and Barclays, indicating potential for stock appreciation.

The company's strong cash flow and undervaluation based on DCF and PE ratio analyses suggest a favorable investment opportunity.

Cigna's consistent dividend growth makes it an attractive option for income-focused investors.